Opus Capital Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.3M Sell
5,317
-11
-0.2% -$2.56K 0.14% 52
2025
Q4
$1.1M Sell
5,328
-651
-11% -$129K 0.12% 55
2025
Q3
$1.11M Sell
5,979
-37
-0.6% -$6.34K 0.12% 51
2025
Q2
$919K Buy
6,016
+540
+10% +$83K 0.11% 55
2025
Q1
$908K Buy
5,476
+1,537
+39% +$240K 0.12% 51
2024
Q4
$570K Buy
3,939
+1,741
+79% +$270K 0.07% 65
2024
Q3
$356K Buy
+2,198
New +$350K 0.04% 88
2024
Q2
Sell
-1,826
Closed -$289K 120
2024
Q1
$289K Sell
1,826
-119
-6% -$18.9K 0.04% 101
2023
Q4
$305K Buy
1,945
+5
+0.3% +$767 0.05% 97
2023
Q3
$302K Buy
1,940
+598
+45% +$98.7K 0.05% 93
2023
Q2
$222K Sell
1,342
-7
-0.5% -$1.13K 0.04% 112
2023
Q1
$209K Buy
1,349
+21
+2% +$3.39K 0.04% 115
2022
Q4
$235K Buy
1,328
+2
+0.2% +$345 0.05% 105
2022
Q3
$217K Buy
1,326
+3
+0.2% +$508 0.05% 98
2022
Q2
$235K Sell
1,323
-79
-6% -$14.1K 0.05% 99
2022
Q1
$249K Sell
1,402
-30
-2% -$5.11K 0.05% 100
2021
Q4
$245K Sell
1,432
-57
-4% -$9.33K 0.05% 93
2021
Q3
$240K Sell
1,489
-21
-1% -$3.58K 0.05% 90
2021
Q2
$249K Buy
1,510
+89
+6% +$14.7K 0.06% 99
2021
Q1
$234K Sell
1,421
-1,182
-45% -$191K 0.06% 107
2020
Q4
$410K Sell
2,603
-2,245
-46% -$331K 0.1% 77
2020
Q3
$722K Sell
4,848
-2,938
-38% -$435K 0.21% 51
2020
Q2
$1.09M Sell
7,786
-124
-2% -$18.1K 0.34% 38
2020
Q1
$1.04M Sell
7,910
-907
-10% -$129K 0.37% 33
2019
Q4
$1.29M Sell
8,817
-20
-0.2% -$2.71K 0.38% 35
2019
Q3
$1.14M Sell
8,837
-22
-0.2% -$2.9K 0.35% 37
2019
Q2
$1.23M Buy
8,859
+1,198
+16% +$166K 0.37% 33
2019
Q1
$1.07M Sell
7,661
-158
-2% -$21.2K 0.29% 47
2018
Q4
$1.01M Buy
7,819
+2
+0% +$279 0.21% 100
2018
Q3
$1.08M Sell
7,817
-1,078
-12% -$143K 0.24% 103
2018
Q2
$1.08M Sell
8,895
-122
-1% -$15.2K 0.26% 102
2018
Q1
$1.16M Sell
9,017
-527
-6% -$71.2K 0.29% 104
2017
Q4
$1.33M Buy
9,544
+531
+6% +$74K 0.29% 98
2017
Q3
$1.17M Sell
9,013
-608
-6% -$80.6K 0.27% 97
2017
Q2
$1.27M Sell
9,621
-1,096
-10% -$140K 0.25% 91
2017
Q1
$1.33M Sell
10,717
-28
-0.3% -$3.35K 0.18% 94
2016
Q4
$1.24M Sell
10,745
-348
-3% -$40.2K 0.18% 83
2016
Q3
$1.31M Sell
11,093
-30
-0.3% -$3.64K 0.27% 83
2016
Q2
$1.35M Sell
11,123
-543
-5% -$61.7K 0.3% 81
2016
Q1
$1.26M Buy
11,666
+2,673
+30% +$277K 0.28% 90
2015
Q4
$924K Sell
8,993
-375
-4% -$37.7K 0.16% 122
2015
Q3
$874K Buy
9,368
+3,170
+51% +$307K 0.15% 125
2015
Q2
$604K Sell
6,198
-4,680
-43% -$469K 0.09% 154
2015
Q1
$1.09M Sell
10,878
-5,830
-35% -$593K 0.17% 118
2014
Q4
$1.75M Sell
16,708
-1,649
-9% -$174K 0.25% 99
2014
Q3
$1.96M Sell
18,357
-17,795
-49% -$1.85M 0.27% 96
2014
Q2
$3.78M Hold
36,152
0.26% 80
2014
Q1
$3.55M Buy
36,152
+1,440
+4% +$134K 0.25% 72
2013
Q4
$3.18M Buy
34,712
+1,176
+4% +$108K 0.18% 79
2013
Q3
$2.91M Buy
33,536
+638
+2% +$57.2K 0.17% 78
2013
Q2
$2.82M Buy
+32,898
New +$2.79M 0.17% 72

Other funds holding JNJ

Opus Capital Group's JNJ Position: Q1 2026 in Review

Opus Capital Group reduced its Johnson & Johnson (JNJ) stake by 0.21% in Q1 2026, selling an estimated $2.56K and leaving 5,317 shares worth $1.3M. The position accounts for 0.14% of the portfolio, ranked #52.

Opus Capital Group first reported a position in JNJ in Q2 2013 and has held it in 51 quarters since. The position peaked at $3.78M in Q2 2014. 4,617 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Opus Capital Group held 5,317 shares of Johnson & Johnson worth $1.3M as of Q1 2026.
  • Opus Capital Group sold 11 Johnson & Johnson shares in Q1 2026, an estimated $2.56K.
  • Johnson & Johnson made up 0.14% of Opus Capital Group's portfolio in Q1 2026, its #52 holding.
  • Opus Capital Group first reported a position in Johnson & Johnson in Q2 2013 and has held it in 51 quarters since.
  • Opus Capital Group's Johnson & Johnson position peaked at $3.78M in Q2 2014.
  • 4,617 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Opus Capital Group's 13F filing for Q1 2026, filed 30 Apr 2026.